Literature DB >> 18059029

The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma.

Renato Talamini1, Jerry Polesel, Michele Spina, Emanuela Chimienti, Diego Serraino, Antonella Zucchetto, Ernesto Zanet, Silvia Franceschi, Umberto Tirelli.   

Abstract

Tobacco smoking and alcohol consumption have not been clearly related to the risk of non-Hodgkin lymphoma (NHL), and the impact of these two factors on survival of NHL patients has received little attention. Cases were 268 subjects with incident histologically-confirmed NHL, admitted as inpatients to the Division of Medical Oncology, between 1983 and 2002. These individuals were enrolled as cases in case-control studies conducted at the same institution over the same period. For all patients clinical (histological subtype, major prognostic factors and treatment) and epidemiological data (smoking and drinking habits) were available. Survival analysis was performed using Kaplan-Meier methods. Hazard ratio (HR) was estimated by Cox proportional hazard model. Compared to never smokers, patients who smoked >or=20 cigarettes/day had higher risks of death (HR = 1.70, 95% confidence interval (CI): 1.06-2.73) and lower survivals at 5 years (60 and 46%, respectively). Likewise, patients who drunk >or=4 drinks/day showed 1.69-fold higher probability of death (95% CI: 1.04-2.76) in comparison to drinkers of <2 drinks/day (5-year survival: 47 and 67%, respectively). When combining exposure to alcohol and tobacco, no excess of death emerged in light drinkers (<4 drinks/day), irrespective of their smoking habits, but higher risks of death emerged among heavy drinkers. In the present study, heavy tobacco smoking, and particularly, heavy alcohol drinking were associated with poor survival in NHL patients. Our findings strongly encourage physicians to advice NHL patients to stop smoking and diminish alcohol consumption to obtain improvements in the course of NHL. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18059029     DOI: 10.1002/ijc.23205

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma.

Authors:  Zanetta S Lamar; Nora Fino; Jodi Palmer; Lindsey Gruber; Bonny B Morris; Olga Raetskaya-Solntseva; LeAnne Kennedy; Rakhee Vaidya; David Hurd; Kenneth Zamkoff
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-12-02

2.  The association of physical activity before and after lymphoma diagnosis with survival outcomes.

Authors:  Priyanka A Pophali; Andrew Ip; Melissa C Larson; Allison C Rosenthal; Matthew J Maurer; Christopher R Flowers; Brian K Link; Umar Farooq; Andrew L Feldman; Cristine Allmer; Susan L Slager; Thomas E Witzig; Thomas M Habermann; Jonathon B Cohen; James R Cerhan; Carrie A Thompson
Journal:  Am J Hematol       Date:  2018-10-17       Impact factor: 10.047

3.  Risk Factors of Non-Hodgkin Lymphoma.

Authors:  Yawei Zhang; Ying Dai; Tongzhang Zheng; Shuangge Ma
Journal:  Expert Opin Med Diagn       Date:  2011-11-01

4.  Pre-diagnosis cigarette smoking and overall survival in non-Hodgkin lymphoma.

Authors:  Nicholas J Ollberding; Andrew M Evens; Briseis Aschebrook-Kilfoy; Donne Bennett D Caces; Dennis D Weisenburger; Sonali M Smith; Brian C-H Chiu
Journal:  Br J Haematol       Date:  2013-08-02       Impact factor: 6.998

Review 5.  New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy.

Authors:  Dai Chihara; Loretta J Nastoupil; Jessica N Williams; Paul Lee; Jean L Koff; Christopher R Flowers
Journal:  Expert Rev Anticancer Ther       Date:  2015-04-11       Impact factor: 4.512

6.  Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.

Authors:  Susan M Geyer; Lindsay M Morton; Thomas M Habermann; Cristine Allmer; Scott Davis; Wendy Cozen; Richard K Severson; Charles F Lynch; Sophia S Wang; Matthew J Maurer; Patricia Hartge; James R Cerhan
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

7.  Cigarette Smoking and Pancreatic Cancer Survival.

Authors:  Chen Yuan; Vicente Morales-Oyarvide; Ana Babic; Clary B Clish; Peter Kraft; Ying Bao; Zhi Rong Qian; Douglas A Rubinson; Kimmie Ng; Edward L Giovannucci; Shuji Ogino; Meir J Stampfer; John Michael Gaziano; Howard D Sesso; Barbara B Cochrane; JoAnn E Manson; Charles S Fuchs; Brian M Wolpin
Journal:  J Clin Oncol       Date:  2017-03-30       Impact factor: 44.544

8.  Tobacco use in the oncology setting: advancing clinical practice and research.

Authors:  Ellen R Gritz; Benjamin A Toll; Graham W Warren
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01       Impact factor: 4.254

9.  Trends in concussion return-to-play timelines among high school athletes from 2007 through 2009.

Authors:  Jennifer M Medina McKeon; Scott C Livingston; Ashley Reed; Robert G Hosey; Williams S Black; Heather M Bush
Journal:  J Athl Train       Date:  2013-10-23       Impact factor: 2.860

10.  Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement.

Authors:  Benjamin A Toll; Thomas H Brandon; Ellen R Gritz; Graham W Warren; Roy S Herbst
Journal:  Clin Cancer Res       Date:  2013-04-09       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.